Testosterone Plus Finasteride Treatment After Spinal Cord Injury

Inclusion Criteria: * Male \> 18 years of age * Traumatic, vascular, or orthopedic spinal cord injury between C2-L3 \>12 months prior to enrollment * Motor incomplete spinal cord (AIS C/D) * Ambulatory dysfunction * Medically stable condition that is asymptomatic for bladder infection, decubiti, cardiopulmonary disease, or other significant medical conditions * Serum total testosterone (\<325 ng/dL) or bioavailable testosterone (\<70 ng/dL) Exclusion Criteria: * Currently participating in another research protocol that may influence study outcomes * Life expectancy \<1 year * History of or current congenital spinal cord injury or other degenerative spinal disorder * Diagnosis of multiple sclerosis, amyotrophic lateral sclerosis, or other neurologic impairment/injury * History of venous thromboembolism within the last 6 months, specifically deep venous thromboembolism and pulmonary embolism, history of recurrent venous thromboembolism or know hereditary thrombophilia * Poorly compensated or uncontrolled cardiovascular disease * Any major cardiovascular event within the last 12 months (defined as a history of acute myocardial infarction, any cardiac revascularization procedure including angioplasty, stenting, or coronary artery bypass grafting, hospitalization due to unstable angina, transient ischemic attack, or stroke) * Any angina that is not controlled on a current medical regimen (Canadian class II, III, or IV) * New York Heart Association (NYHA) class III or IV congest…